The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status
暂无分享,去创建一个
V. Adamo | A. Russo | V. Bazan | G. Bronte | F. Passiglia | S. Rizzo | T. Franchina | C. Natoli | M. De Tursi | A. Russo | E. Gambale | G. Savio | A. Laudani | A. Picone | M. Alú | Giovanni Sortino | Claudia Celesia | L. Blasi | A. Russo | Elisabetta Gambale